A Combination Therapy In Patients With Social Anxiety Disorder

A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder

NCT00470483 ·Status: COMPLETED ·Phase: PHASE1

RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo

NCT00184106 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder

NCT00195598 ·Status: COMPLETED ·Phase: PHASE3

Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder

NCT00074802 ·Status: COMPLETED ·Phase: PHASE3

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)

NCT00658372 ·Status: TERMINATED ·Phase: PHASE3

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)

NCT00658762 ·Status: TERMINATED ·Phase: PHASE3

A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder

NCT00555139 ·Status: COMPLETED ·Phase: PHASE1

Long-term Study Of Paroxetine in Women and Men

NCT00264654 ·Status: COMPLETED ·Phase: PHASE3

A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder

NCT00677352 ·Status: COMPLETED ·Phase: PHASE4

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

NCT00191022 ·Status: COMPLETED ·Phase: PHASE2

Study of Vilazodone to Treat Social Anxiety Disorder

NCT01712321 ·Status: UNKNOWN ·Phase: NA

An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

NCT00374166 ·Status: COMPLETED ·Phase: PHASE2

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

NCT00658008 ·Status: TERMINATED ·Phase: PHASE3

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

NCT01376271 ·Status: COMPLETED

A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder

NCT02432703 ·Status: COMPLETED ·Phase: PHASE2

Combined Treatment for Generalized Anxiety Disorder (GAD)

NCT00620776 ·Status: COMPLETED ·Phase: PHASE2

Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety

NCT06564402 ·Status: RECRUITING ·Phase: NA

A Dose-Response Safety Study of ENX-102 in Patients With GAD

NCT06653296 ·Status: COMPLETED ·Phase: PHASE2

Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)

NCT00557622 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

NCT00238719 ·Status: COMPLETED ·Phase: PHASE3

A Study of NTX-1472 in Social Anxiety Disorder

NCT07323784 ·Status: RECRUITING ·Phase: PHASE2

Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

NCT00836069 ·Status: TERMINATED ·Phase: PHASE3

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)

NCT04220996 ·Status: COMPLETED ·Phase: PHASE4

Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder

NCT00282828 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder

NCT00294346 ·Status: COMPLETED ·Phase: PHASE2